Thursday, 02 April 2020

India News

  • Cliantha uses Acceliant software to manage trials

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: India based contract research organization (CRO), Cliantha Research has implemented Acceliant's eClinical Suite for their clinical trial data management needs. Acceliant is the m...Read more

  • Merck unveils solid dose formulation lab

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: According to Merck's press release, the facilities at the lab were built to provide services and application assistance to the pharmaceutical industry, for classic pharmaceutical...Read more

  • Ranbaxy advisory: All our products are safe and efficacious

    India |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The firm revealed that the advisory was issued in public i...Read more

  • Tripura Malaria death roll rises to 41

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: "At least 41 people, including 31 children, have died and more than 22,000 have fallen ill since the first week of this month. Of the 22,000 affected people, the malaria germ has...Read more

  • Dr. Reddy's, Merck Serono enter partnership

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    Singapore: Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, have entered into a partnership to co-develop a portfolio of biosimilar compounds in onco...Read more

  • Biological E to supply vaccine to Vacsera of Egypt

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

    Singapore: Biological E has entered into a long term supply agreement with Vacsera (and its subsidiary Egyvac), an Egyptian vaccines company under the Ministry of Health of Egypt, for the p...Read more

  • Now Ranbaxy's Mohali unit under FDA scanner

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

    Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, selling adulterated drugs in the US and paying a penalty of $500 millio...Read more

  • India ranks 2nd in terms of total company revenues

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    India emerged as the second largest country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. It made several ...Read more

  • Cold tolerant gene identified in trout fish

    India |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

    New Delhi: A group of scientists at the directorate of Cold Water Fisheries Research, Bhimtal, led by Dr Ashoktaru Barat, principal scientist, have identified and characterized Glycerol pho...Read more

  • Bilcare to implement drug authentication project

    India |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Mumbai: The Council of Scientific and Industrial Research (CSIR), India, under its New Millennium Indian Technology Leadership Initiative (NMITLI) Scheme, has approved the implementation of...Read more

  • DNDi, Cipla to work on ARV therapy for children

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

    Mumbai: The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, has signed a new collaboration with Indian drug manufacturer Ci...Read more

  • FDA continues review of Crofelemer beyond goal date

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Mumbai: The Food and Drug Administration has advised Salix Pharmaceuticals, Mumbai-based Glenmark's collaborative partner, that the new drug application (NDA) for Crofelemer 125 mg tablets ...Read more

  • Biocon clocks revenue worth $121 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Bangalore: Indian biopharma giant Biocon reported healthy growth of 22 percent for Q1 FY14. The firm clocked revenues worth $121 million (Rs723 crore), EBITDA of $29.50 million (Rs175 crore...Read more

  • Trivitron JV to lead immunodiagnostics sector in 3 years

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    Bangalore: Trivitron Healthcare entered in a strategic partnership with Diasorin Group, a global leader in $11 billion immune segment, in order to establish itself in the immunodiagnostic ...Read more

  • Sandoz focuses on developing modern drugs for TB'

    India |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufactures and markets generic drugs as well as pharmaceutical and biotech...Read more

  • What the UK plans to do at Bangalore India BIO?

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    A positive business environment, access to global expertise and the presence of world renowned universities, is helping the UK to nurture some of the most innovative companies. Life science...Read more

  • Accuray announces first two CyberKnife systems in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Accuray, the premier radiation oncology company, announced that Medanta - The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired an...Read more

  • India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising consumption levels in the country and strong demand from export markets. ...Read more